The company’s gross profit totaled $41.5 million, up from 2012’s $38 million. In the first six months of the year, Exactech’s revenue has increased from $113.8 million to $119.9 million, or 5 percent.
So far this year, knee, extremity and hip implant revenue all decreased. However, biologics and spine revenue jumped 6 percent to $12.9 million.
More Articles on Devices:
8 New Spine, Orthopedic Device Launches & Releases
Ceiling-Mounted CT Device Receives FDA Market Approval
Dr. Donald Gajewski Develops IDEO Device to Help Injured Soldiers Walk, Run Again
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
